Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
First Watch Restaurant Group, Inc. released its Q2 2026 financial results, highlighting a 15.2% increase in total revenues to $354.7 million, same-restaurant sales growth of 3.4%, and net income rising to $2.3 million. The company opened 18 new restaurants and updated its fiscal 2026 outlook projecting revenue growth between 12.5% to 14%, and adjus…
Arvinas, Inc. announced the FDA approval of VEPPANU, the first-ever PROTAC degrader approved for breast cancer treatment, and completed a global licensing deal with Rigel Pharmaceuticals. The company reported strong financial results for Q2 2026, driven by increased revenues from partnerships and milestones. Clinical progress includes ongoing Phase…
Odyssey Therapeutics reported its second quarter 2026 results, highlighting positive Phase 2a trial data for its OD-001 program to be presented at a major gastroenterology conference in October. The company plans to initiate Phase 2b monotherapy and Phase 2a combination trials for OD-001 in the second half of 2026, alongside preparing a CTA filing …
TOP Financial Group Limited announced a major strategic initiative to incorporate advanced artificial intelligence technologies across its core brokerage and financial technology businesses. The company plans to develop AI infrastructure encompassing software, hardware, cloud computing, and AI agent deployment to enhance operational efficiency, use…
Insight Molecular Diagnostics Inc. announced it will release its second quarter 2026 financial results on August 10, 2026, followed by a live webinar to discuss the results. The company will also participate in the 11th Annual Needham Virtual MedTech & Diagnostics conference on August 11, 2026, holding one-on-one investor meetings virtually.
Strata Critical Medical, Inc. announced second-quarter 2026 financial results, showing a 60.7% year-over-year revenue increase to $72.5 million. The growth was fueled by organic expansion in logistics and significant contributions from recent clinical business acquisitions. Adjusted EBITDA nearly tripled year-over-year to $7.9 million, with margin …
Aeluma, a NASDAQ-listed semiconductor company, announced the appointment of Jason Taylor as Senior Director of Program and Project Management. With nearly 30 years of semiconductor experience, Taylor will lead program management efforts to commercialize Aeluma's compound semiconductor photonic technologies. This strategic hire comes amid growing co…
Lisata Therapeutics announced the termination of its merger agreement with Kuva Labs and has filed a lawsuit against Kuva for breach of contract seeking damages and a termination fee. The company is actively evaluating strategic alternatives to maximize shareholder value, including possible mergers, acquisitions, asset sales, or liquidation. To con…
Beam Therapeutics announced significant progress in Q2 2026, including dosing the first patient in a pivotal cohort for BEAM-302 in alpha-1 antitrypsin deficiency, completion of dosing in the BEACON trial for sickle cell disease with risto-cel, FDA clearance for BEAM-304 clinical trial in phenylketonuria, and a strong cash position supporting opera…
Certara, Inc. reported a 1% increase in total revenue year-over-year for Q2 2026, with software revenue growing 4% while services revenue declined 3%. The company posted a net loss of $6.1 million due to higher operating expenses and absence of prior year favorable adjustments. Certara completed a $100 million share repurchase program and authorize…
Dianthus Therapeutics announced DNTH312, an internally developed first-in-class bifunctional fusion protein combining claseprubart and TACI to potently inhibit aC1s and BAFF/APRIL pathways. DNTH312 demonstrates comparable potency and half-life to claseprubart and aims to be Phase 1 ready by the end of 2027. This innovative therapy targets severe au…
LGI Homes, Inc. reported strong results for the second quarter of 2026, with an 8.8% increase in home deliveries year-over-year and revenues reaching $516 million. Homebuilding gross margins surpassed previous guidance, and the company reduced its debt significantly, improving its debt-to-capital ratio. Based on this strong performance, LGI Homes r…
Tiziana Life Sciences announced that CEO Ivor Elrifi purchased 667,000 shares at $1.00 each, increasing his total holdings to over 4.4 million shares. The company is advancing its lead candidate, intranasal foralumab, a novel fully human anti-CD3 monoclonal antibody targeting neuroinflammatory diseases like non-active secondary progressive multiple…
Tower Semiconductor reported record revenue of $460 million and net profit of $91 million for Q2 2026, reflecting strong year-over-year growth of 24% and 95% respectively. The company anticipates even higher revenue in Q3 2026 at $520 million, up 31% year-over-year. Tower also announced substantial capacity expansions and raised its 2028 revenue ta…
Cipher Digital Inc. announced accelerated delivery of initial data center capacity at its Black Pearl campus ahead of schedule, secured an option for a new 900 MW Apollo data center site near San Antonio, Texas, and completed project-level financing fully funding the Stingray data center development. These operational and financial milestones demon…
KKR is trading near $106.57 after a pullback from 2025 highs. Fundamentals show sizeable AUM growth, new initiatives (Helix digital infrastructure) and recurring fee engines that should blunt near-term private credit anxiety. Valuation is reasonable for a diversified alternative manager; we outline an actionable long trade with entry, stop, targets…
BellRing Brands Inc. reported Q3 FY 2026 net sales of $570.4 million, a 4% increase year-over-year, with operating profit rising to $65.4 million despite a $10 million inventory charge impacting earnings. The company updated its fiscal year 2026 guidance, projecting net sales between $2.335-$2.375 billion and adjusted EBITDA of $275-$295 million, r…
On Aug. 4, Pfizer reported second-quarter adjusted earnings that surpassed analyst expectations, driven by robust demand for the blood thinner Eliquis. The company slightly raised the lower end of its full-year sales forecast and highlighted its strategy to rely more on newer medicines and the $10 billion Metsera acquisition to diversify revenue aw…
JPMorgan said hedge funds gave up almost 3% of their 2026 gains during July as technology-related positions were unwound amid a wider market reaction to a crude oil price spike linked to the Iran war. Despite the setback, hedge funds remain approximately 8% higher for the year across strategies. The bank highlighted concentrated losses from momentu…
AMD reports second-quarter 2026 results after the close with consensus at $1.61 in EPS and $11.29 billion in revenue. Pre-market trading shows the stock up to $502.30, but history and current market positioning suggest that even a beat may not be sufficient to lift the share price unless management delivers clear guidance on Helios ramp timing, gro…
Rhythm Pharmaceuticals announced promising preliminary Phase 2 data for RM-718, an investigational MC4R agonist, demonstrating an average 11.6% reduction in BMI at 16 weeks among patients with acquired hypothalamic obesity. These results are comparable to existing treatments, with minimal adverse effects such as mild injection site hyperpigmentatio…
The Scotts Miracle-Gro Company announced its mid-range financial targets and capital allocation strategy for fiscal years 2027 to 2029 during its Investor Day 2026 at the NYSE. The company outlined its SMG 2.0 growth strategy focusing on portfolio innovation, omnichannel expansion, market penetration, and operational excellence through technology. …
Kimco Realty Corporation, a leading US REIT specializing in open-air, grocery-anchored shopping centers, announced solid second quarter 2026 results highlighted by record portfolio occupancy of 96.4%, 4.5% growth in funds from operations (FFO) per share, and a 12% dividend increase. The company also raised its full-year 2026 net income and FFO outl…
Senmiao Technology Limited (Nasdaq: AIHS) has hired a strategic government relations advisory firm led by Justin Evans to aid in site development, permitting, incentives, and government stakeholder engagement for its AI data center (AIDC) projects in the United States. This partnership aims to support the company's expansion efforts, including its …
Descartes Systems Group introduced its new AI-powered Free Trade Intelligence (FTI) solution designed to assist manufacturers, importers, and exporters in reducing trade costs by facilitating faster and more accurate qualification for preferential tariff treatment. The solution integrates with ERP systems and leverages AI to analyze complex trade d…
